Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Liver Cancer After Liver Transplantation”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)UnknownNCT04677088
What this trial is testing

TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Xiaoshun He 7
Not applicableStudy completedNCT06233708
What this trial is testing

Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant

Who this might be right for
Hepatocellular Carcinoma RecurrentHepatocellular Carcinoma
Asan Medical Center 2,092
Not applicableStudy completedNCT06720675
What this trial is testing

Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

Who this might be right for
Liver CarcinomaLiver TransplantTumor Recurrence+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 237
Not applicableLooking for participantsNCT06236568
What this trial is testing

Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplant; Complications
Azienda Ospedaliero-Universitaria di Modena 40
Testing effectiveness (Phase 2)WithdrawnNCT02129322
What this trial is testing

Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06041490
What this trial is testing

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsHepatocarcinomaRecurrent Osteosarcoma+1 more
Peking Union Medical College Hospital 88
Not applicableStudy completedNCT03775863
What this trial is testing

AFP Model and Liver Transplantation.

Who this might be right for
Liver CarcinomaLiver Transplant Disorder
Austral University, Argentina 1,200
Not applicableUnknownNCT05876052
What this trial is testing

HOPE to Reduce Tumour Recurrence After LT In Patients With HCC

Who this might be right for
Liver CancerTumor RecurrenceHepatocellular Carcinoma+2 more
University of Bologna 192
Testing effectiveness (Phase 2)Ended earlyNCT05103904
What this trial is testing

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Who this might be right for
Recurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8+5 more
Emory University 3
Early research (Phase 1)UnknownNCT03966209
What this trial is testing

Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Shanghai Zhongshan Hospital 20
Not applicableEnrolling By InvitationNCT07703735
What this trial is testing

Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Liver TransplantationHepatocellular Carcinoma (HCC)
Seoung Hoon Kim 371
Not applicableStudy completedNCT03490461
What this trial is testing

Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Yonsei University 350
Early research (Phase 1)Study completedNCT00844168
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Resectable Adult Primary Liver Cancer+2 more
University of Washington 4
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06409637
What this trial is testing

FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation

Who this might be right for
Liver CancerLiver Transplant
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 62
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT02686372
What this trial is testing

TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 13
Not applicableUnknownNCT03839706
What this trial is testing

Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 20
Not applicableStudy completedNCT06799468
What this trial is testing

Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver TransplantationDeep Learning Model
European Hepatocellular Cancer Liver Transplant Group 1,769
Early research (Phase 1)UnknownNCT02399735
What this trial is testing

Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University 18
Next Page